[HTML][HTML] Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem …
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[PDF][PDF] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson… - Biology of Blood and …, 2007 - scholar.archive.org
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[PDF][PDF] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson… - Biology of Blood and …, 2007 - cyberleninka.org
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[PDF][PDF] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson… - Biology of Blood and …, 2007 - researchgate.net
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[HTML][HTML] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson, L Huebsch… - Biology of Blood and …, 2007 - tctjournal.org
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell …
J Tay, A Tinmouth, D Fergusson… - Biology of blood …, 2007 - pubmed.ncbi.nlm.nih.gov
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell …
J Tay, A Tinmouth, D Fergusson… - Biology of Blood and …, 2007 - europepmc.org
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell …
J Tay, A Tinmouth, D Fergusson, L Huebsch… - Biology of Blood and …, 2007 - infona.pl
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[PDF][PDF] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson, L Huebsch… - Biology of Blood and …, 2007 - core.ac.uk
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
[HTML][HTML] Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic …
J Tay, A Tinmouth, D Fergusson… - Biology of Blood and …, 2007 - astctjournal.org
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …